Cargando…

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo

Cryptococcus neoformans (Cn) is an encapsulated neurotropic fungal pathogen and the causative agent of cryptococcal meningoencephalitis (CME) in humans. Recommended treatment for CME is Amphotericin B (AmpB) and 5-fluorocytosine (5-FC). Though effective, AmpB has displayed numerous adverse side effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munzen, Melissa E., Reguera-Gomez, Marta, Hamed, Mohamed F., Enriquez, Vanessa, Charles-Nino, Claudia L., Dores, Michael R., Alviña, Karina, Martinez, Luis R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120726/ https://www.ncbi.nlm.nih.gov/pubmed/37090670 http://dx.doi.org/10.1101/2023.04.10.536237

Ejemplares similares

Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection
por: Hamed, Mohamed F., et al.
Publicado: (2023)

Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents
por: Lee, Hiu Ham, et al.
Publicado: (2023)

Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System
por: Hamed, Mohamed F., et al.
Publicado: (2023)

Cerebral cryptococcosis with pseudo‐meningiomatous revelation?
por: Hazim, Asmaa, et al.
Publicado: (2020)

Cryptococcosis
por: Maziarz, Eileen K., et al.
Publicado: (2014)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
por: Caltagirone, Carlo, et al.
Publicado: (2015)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Cryptococcosis
por: Haley, Lenore D.
Publicado: (1957)

Cryptococcosis
por: Forrestel, Amy K.
Publicado: (2018)

Pulmonary Cryptococcosis
por: Howard-Jones, Annaleise R., et al.
Publicado: (2022)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
por: Assogna, Martina, et al.
Publicado: (2022)

Disseminated cryptococcosis with gastric and thyroid involvement
por: Dhillon, Ramandeep, et al.
Publicado: (2021)

Cryptococcosis and Cryptococcus
por: Francisco, Elaine Cristina, et al.
Publicado: (2021)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats
por: Vacondio, Federica, et al.
Publicado: (2015)

Possible Anandamide and Palmitoylethanolamide involvement in human stroke
por: Naccarato, Marcello, et al.
Publicado: (2010)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
por: Seol, Tai-Kyung, et al.
Publicado: (2017)

Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome
por: Paladini, Antonella, et al.
Publicado: (2017)

Palmitoylethanolamide: Prenatal Developmental Toxicity Study in Rats
por: Deshmukh, Narendra S., et al.
Publicado: (2021)

Palmitoylethanolamide: A Natural Compound for Health Management
por: Clayton, Paul, et al.
Publicado: (2021)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide
por: Scuderi, Caterina, et al.
Publicado: (2011)

Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan
por: Chen, Chang-Hua, et al.
Publicado: (2015)

Pulmonary Cryptococcosis Mimicking Lung Cancer
por: Eremiev, Simeon, et al.
Publicado: (2022)

Experimental Models of Cryptococcosis
por: Sabiiti, Wilber, et al.
Publicado: (2012)

Miliary pulmonary cryptococcosis
por: Kelly, Shane, et al.
Publicado: (2014)

Cutaneous and pulmonary cryptococcosis()()
por: Markman, Deborah Lucena, et al.
Publicado: (2020)

Cryptococcosis and unexpected death
por: Tu, Abbie, et al.
Publicado: (2021)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential
por: Nestmann, Earle R.
Publicado: (2016)

Management of Cryptococcosis: How Are We Doing?
por: Perfect, John R
Publicado: (2007)

Retrospective analysis of pulmonary cryptococcosis and extrapulmonary cryptococcosis in a chinese tertiary hospital
por: Shi, Jiejun, et al.
Publicado: (2023)

Genetic Manipulation of Palmitoylethanolamide Production and Inactivation in Saccharomyces cerevisiae
por: Muccioli, Giulio G., et al.
Publicado: (2009)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery
por: Puglia, Carmelo, et al.
Publicado: (2018)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

First case of feline cryptococcosis in Hong Kong, caused by Cryptococcus neoformans
por: Almendros, Angel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qfk068icqoqcktg1d7h3okl8aa